CRISPR Assays for Disease Diagnosis: Progress to and Barriers Remaining for Clinical Applications is a research paper published in Advanced Science (2023). On theSindex it has a DataRank of 0. It has been cited 49 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01CA252965
National Institutes of Health
Grant: R01HD090927
National Institutes of Health
Grant: R01AI144168
National Institutes of Health
Grant: R01HD103511
National Institutes of Health
Grant: R21NS130542
U.S. Department of Defense
Grant: W8IXWH1910926
NIAID NIH HHS
Grant: R01 AI175618
NIAID NIH HHS
Grant: R01 AI177986
National Institutes of Health
Grant: 7R01HD090927-04
Direct quantitation of the circulating Mtb-peptidome for pediatric TB management
National Institutes of Health
Grant: 1U01CA252965-01
Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples
National Institutes of Health
Grant: 1R21NS130542-01
Quantification of brain-derived extracellular vesicle microRNAs in blood by a liposome-mediated CRISPR assay for traumatic brain injury detection
National Institutes of Health
Grant: 5R01AI144168-03
A nanopore biosensor for leveling Mtb antigens in blood
National Institutes of Health
Grant: 5R01HD103511-05
Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP
FWCI
4.67
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals